{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:18:51Z","timestamp":1762917531000},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ygyno.2014.06.030","type":"journal-article","created":{"date-parts":[[2014,7,5]],"date-time":"2014-07-05T10:45:40Z","timestamp":1404557140000},"page":"125-132","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy"],"prefix":"10.1016","volume":"135","author":[{"given":"Lingling","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2014.06.030_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.030_bb0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1072-7515(03)00234-5","article-title":"Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications","volume":"197","author":"Morice","year":"2003","journal-title":"J Am Coll Surg"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.030_bb0015","first-page":"289","article-title":"Ovarian cancer: lymph node metastases","volume":"30","author":"Balbi","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2014.06.030_bb0020","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1525-1438.2007.00931.x","article-title":"Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer","volume":"17","author":"Harter","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.030_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0090-8258(91)90099-Q","article-title":"Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer","volume":"40","author":"Burghardt","year":"1991","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ygyno.2014.06.030_bb0030","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.biomaterials.2004.04.008","article-title":"Preparation and characterization of methoxy poly(ethylene glycol)\/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs","volume":"26","author":"Park","year":"2005","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.030_bb0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2013.01.001","article-title":"Nanotoxicological classification system (NCS) \u2014 a guide for the risk-benefit assessment of nanoparticulate drug delivery systems","volume":"84","author":"Keck","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.ygyno.2014.06.030_bb0040","first-page":"1544","article-title":"A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug nanoscale","volume":"5","author":"Knezevic","year":"2013"},{"issue":"12","key":"10.1016\/j.ygyno.2014.06.030_bb0045","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s11095-004-7667-5","article-title":"A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug","volume":"21","author":"Stevens","year":"2004","journal-title":"Pharm Res"},{"issue":"1-2","key":"10.1016\/j.ygyno.2014.06.030_bb0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2006.02.027","article-title":"A folate receptor-targeted liposomal formulation for paclitaxel","volume":"316","author":"Wu","year":"2006","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.ygyno.2014.06.030_bb0055","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.addr.2004.01.008","article-title":"Folate-targeted chemotherapy","volume":"56","author":"Leamon","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"issue":"17","key":"10.1016\/j.ygyno.2014.06.030_bb0060","first-page":"6551","article-title":"In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice","volume":"9","author":"Gabizon","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.ygyno.2014.06.030_bb0065","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","article-title":"Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration","volume":"27","author":"Gao","year":"2006","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.ygyno.2014.06.030_bb0070","article-title":"Expression of gonadotropin and active receptor messenger ribonucleic acid in human ovarian epithelial neoplasms","volume":"6","author":"K.T.","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.030_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/gyno.1999.5628","article-title":"Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone","volume":"76","author":"Zheng","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"16","key":"10.1016\/j.ygyno.2014.06.030_bb0080","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1158\/0008-5472.CAN-08-4721","article-title":"Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo","volume":"69","author":"Zhang XY","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.030_bb0085","first-page":"185","article-title":"Follicle stimulating hormone receptor mediated gene delivery to target ovarian carcinoma in vitro","volume":"6","author":"C.J.","year":"2012","journal-title":"Asian Biomed (Res Rev News)"},{"issue":"5","key":"10.1016\/j.ygyno.2014.06.030_bb0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archsurg.1966.01330050143023","article-title":"Polylactic acid for surgical implants","volume":"93","author":"Kulkarni","year":"1966","journal-title":"Arch Surg"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.030_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00280-006-0256-z","article-title":"Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting","volume":"59","author":"Lu","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1-2","key":"10.1016\/j.ygyno.2014.06.030_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0303-7207(00)00340-3","article-title":"Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer","volume":"172","author":"Parrott JA","year":"2001","journal-title":"Mol Cell Endocrinol"},{"issue":"16","key":"10.1016\/j.ygyno.2014.06.030_bb0105","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1158\/0008-5472.CAN-08-4721","article-title":"Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo","volume":"69","author":"Zhang","year":"2009","journal-title":"Cancer Res"},{"issue":"1-2","key":"10.1016\/j.ygyno.2014.06.030_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(03)00295-3","article-title":"Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles","volume":"262","author":"Panyam","year":"2003","journal-title":"Int J Pharm"},{"issue":"31","key":"10.1016\/j.ygyno.2014.06.030_bb0115","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1016\/j.biomaterials.2011.07.004","article-title":"Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery","volume":"32","author":"Guo","year":"2011","journal-title":"Biomaterials"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814010713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814010713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T12:50:35Z","timestamp":1565614235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814010713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0090825814010713"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.06.030","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}